SREBF1 and obesity disorder: Studies in rats with diet-induced obesity showed that soy isoflavones in a HFD significantly stimulated insulin secretion, decreased PPAR-γ, GLUT 2, and SREBP-1 expression, and ameliorating hyperinsulinemia observed during obesity [39].